Arlton v. Schraut

936 N.E.2d 831, 2010 Ind. App. LEXIS 2063, 2010 WL 4472126
CourtIndiana Court of Appeals
DecidedNovember 9, 2010
Docket79A02-0906-CV-541
StatusPublished
Cited by10 cases

This text of 936 N.E.2d 831 (Arlton v. Schraut) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arlton v. Schraut, 936 N.E.2d 831, 2010 Ind. App. LEXIS 2063, 2010 WL 4472126 (Ind. Ct. App. 2010).

Opinion

OPINION

MATHIAS, Judge.

Appellant-Plaintiff Paul Arlton ("Ar-ton") brought a medical malpractice action against Appellees-Defendants Gary Schraut, M.D. ("Dr. Schraut"), and the Lafayette Retina Clinic ("LRC") (collectively "the Medical Care Providers"), alleging that Arlton had suffered permanent injury to his eye as a result of laser eye surgery performed by Dr. Schraut. The jury returned a verdict in favor of the Medical Care Providers. Arlton appeals and presents three issues:

I. Whether the trial court abused its discretion when it sustained Schraut's objections to Arlton's | proffer of printed, enlarged copies of angiograms depicting Ariton's retina;
II. Whether the trial court abused its discretion when it refused to provide the jury with access to digital evidence during deliberations; and
Whether the trial court abused its discretion in refusing Arlton's tendered instruction informing the jury that, if they so desired, they could review the digital evidence during deliberations. IIL.

We reverse and remand.

Statement of Facts

In the late 1980s, Arlton was diagnosed with choroidal neovaseularization ("CNV") in his left eye. CNV is a condition which occurs when there is abnormal growth of blood vessels near the retina that, if left untreated, can cause significant loss of vision and, ultimately, blindness. Ariton's CNV was first treated in 1987 by means of "photocoagulation"-laser eye surgery which cauterizes and destroys the abnormal growth of blood vessels. These procedures left a dark scar in the retina of Ariton's left eye located outside the central area of vision, and the sear caused a corresponding blind spot in Ariton's peripheral vision.

Ariton was advised by his prior physician to monitor his blind spot for signs of recurrence of the CNV. He did so by periodically taping a piece of paper to the wall and drawing around the edges of the blind spot he perceived in his left eye using a pencil. By comparing these drawings, Ariton could see if there were any changes in the extent of his blind spot.

In 1989, through the use of this tracing procedure, Arlton noticed changes in his blind spot and again underwent laser pho-tocoagulation surgery to treat the recurrence of his CNV. This surgery caused an increase in the size of the sear and corresponding blind spot in Arlton's vision. After this surgery, Arlton continued to monitor his blind spot, but noted no problems until 2002, when he noticed a flickering or flashing at the edge of his blind spot. At that time, he again traced his blind spot, and the tracing revealed a bulge in the sear. Arlton then went to the emergency room, where he was referred to Dr. Schraut.

Dr. Schraut examined Arlton's eye and observed that part of his retina near the sear was swollen. Dr. Schraut believed *834 this area to be a recurrence of the CNV, which would require further laser surgery. To confirm his diagnosis, Dr. Schraut ordered a fluorescein angiogram, a process in which a fluorescent dye was injected into Arlton's blood. An angiogram technician then took a series of photographs of Arlton's retina as the dye passed through the blood vessels in his retina. The results of the angiogram were recorded in a series of photos showing the amount of time that had passed since the dye was injected into the blood. The initial angio-gram photos taken in September of 2002 revealed that Arlton's CNV was not recurring. However, subsequent angiogram photos taken in October 2002 did indicate that Arlton's CNV had recurred.

On November 5, 2002, Dr. Schraut performed laser photocoagulation surgery on Ariton's left eye to treat the recurrence of CNV. Arlton and Dr. Schraut agreed to take a conservative approach to the surgery by treating only the edge of the affected area and then scheduling a followup exam to determine if any further treatments would be necessary. Arlton understood that he could have unexplained vision loss following the laser treatment and did not have any questions for Dr. Schraut before the procedure began.

During the surgery, Dr. Schraut saw that the new growth of blood vessels in Arilton's eye was closer to the center of his vision than the previous sear. According to Arliton, during the procedure, a lens was placed against his eye, and he saw an intense light around his left eye. Arlton further explained that "in about two or three seconds that light went from the center of [his] vision toward the sear and then there was suddenly a click ... and a large flash." Tr. Vol. I, p. 128. A black, wedge-shaped spot then appeared in the center of Arlton's vision.

According to Dr. Schraut, when he made the first shot with the laser, Ariton jumped, and the shape of the first laser spot on Arlton's retina reflected that Arl-ton had moved. Arlton claims that Dr. Schraut told him that "something jumped-that spot jumped [al thirty see-ond of an inch," and "that doesn't matter(,] it's in the sear." Id. Although Dr. Schraut testified that 1/32 of an inch is "gigantic" in terms of retinal surgery, Tr. Vol. III, p. 127, Ariton claims Dr. Schraut told him at the time that it would not matter because the laser spot was in the area of the existing sear on Arlton's retina. Dr. Schraut, however, denies that he placed the laser spot within the existing sear and denies having ever admitted to such.

After the first laser spot had been made, Dr. Schraut asked Arlton if he wanted to continue with the surgery and also asked if he wanted him to take a photo of the first spot before continuing. Arlton told Dr. Schraut to continue the surgery. Dr. Schraut therefore proceeded to place forty-three laser spots to cauterize the area of abnormal growth of blood vessels.

The dark, wedge-shaped spot in Arlton's vision did not go away, and he returned to Dr. Schraut's office the day after surgery. Arlton claims that Dr. Schraut told him that the spot was probably caused by an area of swelling on his retina, and that he should call if it did not go away within a few days. Arlton returned to Dr. Schraut on November 27, 2002, at which time another fluorescein angiogram was taken of Ariton's retina. The angiogram indicated that Arlton's CNV had been treated and that the area of swelling had gone down, but the black spot in Ariton's central vision remained. Dr. Schraut referred Ariton to Dr. Thomas Caiulla, who determined that there were no stray laser spots that had caused Arlton's loss of vision. Another physician, Dr. Steven Virata, viewed Arl- *835 ton's angiogram and determined that there was no obvious explanation for Arlton's vision loss.

Eventually, Arlton was examined by Dr. Morton Goldberg ("Dr. Goldberg"), a professor of ophthalmology at the Johns Hopkins University who specializes in retinal and macular diseases and treatment. Dr. Goldberg ultimately concluded that the wedge-shaped blind spot in Arlton's central vision was caused by Dr. Schraut having placed a new laser burn spot within the area of Ariton's pre-existing sear. According to Dr. Goldberg, the scar tissue is darker and absorbs more heat from the laser and also is thinner than the other parts of the retina. Therefore, there is a higher likelihood of a laser spot in the existing sear tissue to burn nerve fibers that carry the visual information to the brain. In Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
936 N.E.2d 831, 2010 Ind. App. LEXIS 2063, 2010 WL 4472126, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arlton-v-schraut-indctapp-2010.